+467.0%
MRNA vs CCJ
+22.0%
+445.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CCJ | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -0.8% | +6.1% | +5.7% |
| 7D | -1.1% | -4.0% | +2.9% | +0.5% |
| 30D | +126.1% | -2.4% | +128.5% | +129.3% |
| 3M | +190.0% | -2.3% | +192.3% | +192.9% |
| 6M | +157.2% | -16.2% | +173.4% | +165.8% |
| YTD | +388.2% | +5.7% | +382.5% | +408.1% |
| 1Y | +467.0% | +21.3% | +445.8% | +509.7% |
| All | +467.0% | +22.0% | +445.0% | +509.7% |
Cumulative growth
Daily Returns
Daily percentage return beside CCJ.
Daily Out/Under-Performance
Portfolio return minus CCJ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CCJ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CCJ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling